Lehmann K A, Sipakis K, Gasparini R, van Peer A
Department of Anaesthesiology and Operative Intensive Care Medicine, University of Cologne, Germany.
Acta Anaesthesiol Scand. 1993 Feb;37(2):176-80. doi: 10.1111/j.1399-6576.1993.tb03696.x.
The pharmacokinetics of sufentanil were studied in 56 surgical patients after an intravenous bolus of 2 micrograms kg-1, in association with neurolept analgesia or volatile anaesthetics (halothane, enflurane and isoflurane). Plasma concentrations of sufentanil were measured by radioimmunoassay. The kinetics of sufentanil were comparable under neurolept analgesia and under anaesthesia with halothane, enflurane or isoflurane. The overall mean elimination half-life was 182 min, Vdss 169 l and the plasma clearance 910 ml min-1. Except for the isoflurane subgroup, there was no significant correlation between half-life, the volume of distribution or clearance with age (24-77 years) or body weight (45-95 kg).
在56例外科手术患者静脉注射2微克/千克舒芬太尼后,结合神经安定镇痛或挥发性麻醉剂(氟烷、恩氟烷和异氟烷),研究了舒芬太尼的药代动力学。通过放射免疫分析法测定血浆中舒芬太尼的浓度。在神经安定镇痛以及使用氟烷、恩氟烷或异氟烷麻醉的情况下,舒芬太尼的动力学情况相当。总体平均消除半衰期为182分钟,稳态分布容积为169升,血浆清除率为910毫升/分钟。除异氟烷亚组外,半衰期、分布容积或清除率与年龄(24 - 77岁)或体重(45 - 95千克)之间均无显著相关性。